Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children

Paulien A M A Raymakers-Janssen1, Marc Lilien2, Ingrid A van Kessel3

  • 1Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA, Utrecht, The Netherlands. p.a.m.a.raymakers-janssen@umcutrecht.nl.

Insights

Citrate anticoagulation in pediatric continuous renal replacement therapy (CRRT) significantly extends circuit survival time compared to heparin. This study demonstrates citrate

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Biomedical Engineering

Background:

  • Heparin is the standard anticoagulant for adult continuous renal replacement therapy (CRRT).
  • Limited data exists on citrate's safety and efficacy in pediatric CRRT, especially in infants and toddlers.
  • Adverse effects of citrate in this population are not well-documented.

Purpose of the Study:

  • To prospectively evaluate the use of citrate as an anticoagulant in critically ill small children undergoing CRRT.
  • To compare circuit survival time between citrate and heparin anticoagulation in pediatric CRRT.
  • To assess the safety of citrate, including toxicity and electrolyte balance, in this patient group.

Main Methods:

  • A prospective study involving critically ill children who underwent CRRT with small filters.
  • Patients received either heparin or citrate anticoagulation per a strict protocol.
  • Primary outcome was circuit survival time; secondary outcomes included alkalosis, citrate toxicity, and red blood cell transfusions.

Main Results:

  • Citrate use resulted in significantly longer median circuit survival time (45.2 hours) compared to heparin (21 hours) (p < 0.001).
  • No citrate toxicity was observed in patients receiving citrate anticoagulation.
  • No significant differences in electrolyte balance or red blood cell transfusions were noted between the two groups.

Conclusions:

  • Regional citrate anticoagulation significantly prolongs circuit survival time in pediatric CRRT, enhancing treatment efficiency.
  • Citrate is a safe and effective anticoagulant for CRRT in critically ill small children.
  • These findings support the wider adoption of citrate in pediatric CRRT.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.4K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
287
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
407
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.8K